Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients.

IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY
Zhi-Bin Wang, Bing Zhu, Ming-Ming Meng, Yi-Fan Wu, Yu Zhang, Dong-Ze Li, Hua Tian, Fu-Chuan Wang, Yi-Fan Lv, Qiu-Xia Ye, Fu-Quan Liu
{"title":"Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients.","authors":"Zhi-Bin Wang, Bing Zhu, Ming-Ming Meng, Yi-Fan Wu, Yu Zhang, Dong-Ze Li, Hua Tian, Fu-Chuan Wang, Yi-Fan Lv, Qiu-Xia Ye, Fu-Quan Liu","doi":"10.4254/wjh.v17.i3.103261","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Portal hypertension (PHT), a complication of liver cirrhosis, is sometimes managed with transjugular intrahepatic portosystemic shunt (TIPS) to reduce portal pressure. Although effective, TIPS poses risks, including hepatic encephalopathy (HE). This study investigates whether a significant reduction in the portal pressure gradient (PPG) after TIPS improves outcomes in PHT patients.</p><p><strong>Aim: </strong>To evaluate the impact of post-TIPS PPG reduction on clinical outcomes and explore the relationship between PPG reduction and portal vein diameter.</p><p><strong>Methods: </strong>This retrospective cohort study included 815 patients with PHT who underwent TIPS at two tertiary hospitals between 2014 and 2022. Patients were categorized based on whether they achieved a 50% reduction in PPG. Propensity score matching was applied to balance baseline characteristics. Kaplan-Meier analysis assessed clinical outcomes, including rebleeding, HE, liver failure, and hepatocellular carcinoma. Cox regression identified risk factors, and Spearman correlation analyzed the relationship between PPG reduction and portal vein diameter.</p><p><strong>Results: </strong>Patients with a PPG reduction > 50% had significantly lower risks of rebleeding (<i>P</i> = 0.004), shunt dysfunction (<i>P</i> = 0.002), and mortality (<i>P</i> = 0.024) compared to those with a PPG reduction ≤ 50%. However, these patients faced higher risks of HE (<i>P</i> < 0.001) and liver failure (<i>P</i> = 0.003). A significant negative correlation was observed between the percentage of PPG reduction and portal vein diameter (ρ = -0.632, <i>P</i> < 0.001), suggesting that patients with smaller portal vein diameters may achieve greater PPG reductions.</p><p><strong>Conclusion: </strong>A significant PPG reduction following TIPS is associated with improved clinical outcomes, including reduced risks of rebleeding, shunt dysfunction, hepatocellular carcinoma, and mortality, though it increases HE and liver failure risks. The observed correlation between portal vein diameter and PPG reduction highlights the potential role of portal vein anatomy in predicting TIPS efficacy, warranting further investigation.</p>","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":"17 3","pages":"103261"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11959671/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v17.i3.103261","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Portal hypertension (PHT), a complication of liver cirrhosis, is sometimes managed with transjugular intrahepatic portosystemic shunt (TIPS) to reduce portal pressure. Although effective, TIPS poses risks, including hepatic encephalopathy (HE). This study investigates whether a significant reduction in the portal pressure gradient (PPG) after TIPS improves outcomes in PHT patients.

Aim: To evaluate the impact of post-TIPS PPG reduction on clinical outcomes and explore the relationship between PPG reduction and portal vein diameter.

Methods: This retrospective cohort study included 815 patients with PHT who underwent TIPS at two tertiary hospitals between 2014 and 2022. Patients were categorized based on whether they achieved a 50% reduction in PPG. Propensity score matching was applied to balance baseline characteristics. Kaplan-Meier analysis assessed clinical outcomes, including rebleeding, HE, liver failure, and hepatocellular carcinoma. Cox regression identified risk factors, and Spearman correlation analyzed the relationship between PPG reduction and portal vein diameter.

Results: Patients with a PPG reduction > 50% had significantly lower risks of rebleeding (P = 0.004), shunt dysfunction (P = 0.002), and mortality (P = 0.024) compared to those with a PPG reduction ≤ 50%. However, these patients faced higher risks of HE (P < 0.001) and liver failure (P = 0.003). A significant negative correlation was observed between the percentage of PPG reduction and portal vein diameter (ρ = -0.632, P < 0.001), suggesting that patients with smaller portal vein diameters may achieve greater PPG reductions.

Conclusion: A significant PPG reduction following TIPS is associated with improved clinical outcomes, including reduced risks of rebleeding, shunt dysfunction, hepatocellular carcinoma, and mortality, though it increases HE and liver failure risks. The observed correlation between portal vein diameter and PPG reduction highlights the potential role of portal vein anatomy in predicting TIPS efficacy, warranting further investigation.

降低门静脉压力梯度对门脉高压症患者经颈静脉肝内门体分流术后疗效的影响。
背景:门静脉高压(PHT)是肝硬化的一种并发症,有时通过经颈静脉肝内门静脉系统分流术(TIPS)来降低门静脉压力。TIPS虽然有效,但也存在风险,包括肝性脑病(HE)。本研究探讨TIPS后门静脉压力梯度(PPG)的显著降低是否能改善PHT患者的预后。目的:评价tips术后PPG降低对临床疗效的影响,探讨PPG降低与门静脉内径的关系。方法:本回顾性队列研究纳入了2014年至2022年在两家三级医院接受TIPS治疗的815例PHT患者。根据患者是否达到PPG减少50%进行分类。倾向评分匹配用于平衡基线特征。Kaplan-Meier分析评估了临床结果,包括再出血、HE、肝功能衰竭和肝细胞癌。Cox回归分析危险因素,Spearman相关分析PPG降低与门静脉内径的关系。结果:与PPG降低≤50%的患者相比,PPG降低50%的患者再出血(P = 0.004)、分流功能障碍(P = 0.002)和死亡率(P = 0.024)的风险显著降低。然而,这些患者面临更高的HE (P < 0.001)和肝衰竭(P = 0.003)的风险。PPG降低百分比与门静脉直径呈显著负相关(ρ = -0.632, P < 0.001),提示门静脉直径越小的患者PPG降低程度越高。结论:TIPS后PPG的显著降低与临床结果的改善相关,包括再出血、分流功能障碍、肝细胞癌和死亡率的降低,尽管它增加了HE和肝功能衰竭的风险。观察到的门静脉直径与PPG减少之间的相关性突出了门静脉解剖在预测TIPS疗效方面的潜在作用,值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World Journal of Hepatology
World Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.10
自引率
4.20%
发文量
172
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信